Featuring:
Anthony Caggiano, M.D., Ph.D., Chief Medical Officer and Head of R&amp;D, Cognition Therapeutics
James Galvin, M.D., MPH, University of Miami Miller School of Medicine, Director of the Comprehensive Center for Brain Health
Principal Investigator of the SHIMMER Study

Index:







Episode 2: Building on Amyloid Lowering: Key Insights from Recent Data and Prospects for Complementary Therapeutic Approaches

Cognition Therapeutics's “Conversations” series will feature virtual fireside chats with neuroscience experts who will discuss advances in the research and treatment of Alzheimer’s disease, dementia with Lewy bodies (DLB), and other age-related neurodegenerative conditions. All episodes are available to watch as video as cogrx.com/conversations.